Guggenheim Upgrades Health Catalyst Inc. (HCAT) to Buy
Tweet
Share
E-mailGet Alerts HCAT Hot Sheet
Price: $2.28 --0%
Rating Summary:
10 Buy, 9 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 7 | New: 12
Rating Summary:
10 Buy, 9 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 7 | New: 12
Join SI Premium – FREE
Guggenheim analyst Jack Wallace upgraded Health Catalyst Inc. (NASDAQ: HCAT) from Neutral to Buy with a price target of $14.00.
For an analyst ratings summary and ratings history on Health Catalyst Inc. click here. For more ratings news on Health Catalyst Inc. click here.
Shares of Health Catalyst Inc. closed at $9.94 yesterday.
You May Also Be Interested In
- B.Riley Upgrades AST Spacemobile (ASTS) to Buy
- HSBC Upgrades Bayerische Motoren Werke AG (BMW:GR) (BMWYY) to Buy
- Wells Fargo Upgrades SBA Communications (SBAC) to Overweight
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
